Sites Medical and Integrity Implants Enter License Agreement
Sites Medical entered into an agreement to license OsteoSync™ Ti technology to Integrity Implants for its use in expandable interbody devices....
Sites Medical entered into an agreement to license OsteoSync™ Ti technology to Integrity Implants for its use in expandable interbody devices....
Via terms of a definitive agreement with TPG Capital, Exactech is slated to become a privately-held company in 1Q18....
ORTHOWORLD estimates that global orthobiologic product sales account for ~10% of the orthopaedic market's revenue, overall. In 2016, that translated...
Orthocell appointed Surgical Specialties as exclusive distributor in Australia and New Zealand for Ortho-ATI® and Ortho-ACI® cell therapies for tendon and cartilage regeneration. ...
Smith & Nephew’s Chief Executive Officer, Olivier Bohuon, announced his intention to retire by the end of 2018 after seven years in...
Musculoskeletal Transplant Foundation changed its name to MTF Biologics....
LifeLink Tissue Bank will provide allografts to treat sports, orthopaedic and spine injuries to HCT Regenerative, for distribution in Taiwan. ...
Bone Therapeutics signed an exclusive license agreement with Asahi Kasei to develop and commercialize PREOB® autologous bone cell therapy....
Artoss entered into a Defense Acquisition Purchasing Agreement with Owens & Minor for U.S. Department of Defense access to NanoBone bone graft....
ApiFix granted exclusive distribution rights to Joint Solutions Alliance for its scoliosis treatment in Canada....
Login
Register for a free account
As a guest member you get access to more articles and videos every month.